FDA Taps Cerner Enviza, John Snow Labs for AI-driven Drug Safety Study
The Food and Drug Administration has enlisted Oracle subsidiary Cerner Enviza and John Snow Labs to use artificial intelligence, machine learning and natural language processing to help boost drug safety. The collaboration is part of FDA’s Sentinel Initiative, a two-year project that aims to analyze electronic clinical notes to understand drug side effects, Oracle said […] More